Does OFATUMUMAB Cause Product supply issue? 149 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 149 reports of Product supply issue have been filed in association with OFATUMUMAB (ARZERRA). This represents 0.5% of all adverse event reports for OFATUMUMAB.
149
Reports of Product supply issue with OFATUMUMAB
0.5%
of all OFATUMUMAB reports
0
Deaths
18
Hospitalizations
How Dangerous Is Product supply issue From OFATUMUMAB?
Of the 149 reports, 18 (12.1%) required hospitalization, and 1 (0.7%) were considered life-threatening.
Is Product supply issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OFATUMUMAB. However, 149 reports have been filed with the FAERS database.
What Other Side Effects Does OFATUMUMAB Cause?
Fatigue (5,202)
Headache (4,430)
Pain (3,382)
Chills (3,372)
Pyrexia (3,370)
Influenza like illness (2,727)
Nausea (1,688)
Multiple sclerosis relapse (1,525)
Covid-19 (1,435)
Asthenia (1,393)
What Other Drugs Cause Product supply issue?
SECUKINUMAB (357)
LENALIDOMIDE (310)
CANNABIDIOL (298)
APREMILAST (266)
HUMAN IMMUNOGLOBULIN G (169)
ELTROMBOPAG OLAMINE (140)
HUMAN C1-ESTERASE INHIBITOR (117)
OXCARBAZEPINE (109)
CARBAMAZEPINE (98)
POMALIDOMIDE (92)
Which OFATUMUMAB Alternatives Have Lower Product supply issue Risk?
OFATUMUMAB vs OFLOXACIN
OFATUMUMAB vs OLANZAPINE
OFATUMUMAB vs OLANZAPINE\SAMIDORPHAN L-MALATE
OFATUMUMAB vs OLAPARIB
OFATUMUMAB vs OLARATUMAB